PBYI - Puma Biotechnology - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

PBYI is currently covered by 2 analysts with an average price target of $14.8. This is a potential upside of $9.22 (165.23%) from yesterday's end of day stock price of $5.58.

Puma Biotechnology's activity chart (see below) currently has 141 price targets and 103 ratings on display. The stock rating distribution of PBYI is 88.89% BUY and 11.11% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 55.26% with an average time for these price targets to be met of 98.08 days.

Highest price target for PBYI is $7, Lowest price target is $4, average price target is $14.8.

Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 01-Mar-2024. First documented stock forecast 23-Jan-2015.

Currently out of the existing stock ratings of PBYI, 8 are a BUY (88.89%), 1 are a HOLD (11.11%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

7

$1.42 (25.45%)

8

27 days ago

0/8 (0%)

$1.11 (18.85%)

Hold

4

$-1.58 (-28.32%)

7

4 months 25 days ago

5/10 (50%)

$1.22 (43.88%)

85

Hold

7

$1.42 (25.45%)

9

2 years 4 months 23 days ago

4/5 (80%)

$2.99 (74.56%)

249

Sell

5

$-0.58 (-10.39%)

6

2 years 4 months 23 days ago

5/7 (71.43%)

$0.99 (24.69%)

261

Buy

11

2 years 5 months 27 days ago

11/24 (45.83%)

$3.88 (54.49%)

157

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PBYI (Puma Biotechnology) average time for price targets to be met?

On average it took 98.08 days on average for the stock forecasts to be realized with a an average price target met ratio 55.26

Which analyst has the current highest performing score on PBYI (Puma Biotechnology) with a proven track record?

YIGAL NOCHOMOVITZ

Which analyst has the most public recommendations on PBYI (Puma Biotechnology)?

Yigal Nochomovitz works at CITI and has 20 price targets and 14 ratings on PBYI

Which analyst is the currently most bullish on PBYI (Puma Biotechnology)?

Thomas Shrader with highest potential upside - $124.42

Which analyst is the currently most reserved on PBYI (Puma Biotechnology)?

Chris Shibutani with lowest potential downside - -$1.58

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?